Global Market Study on Photodynamic Therapy: Introduction of Drug Devices Combination to Renew Interest


Photodynamic Therapy  Market
  • Published On : Apr-2019 |
  • Pages : 254 Pages |
  • Format : PPT PDF Excel Word

Increasing Focus of Manufacturers on the Launch of Phototherapy Drug-Device Combinations is Creating Significant Growth Opportunities

The Photodynamic Therapy (PDT) market is primarily dominated by the sales of photosensitizer drugs. As seen in drug development, market players are increasing the complexity of drug molecules to prevent them from being replicated by competitors. Similarly, in the photodynamic therapy market, players offering treatment avenues are seeking innovative routes to the market through the launch of combination products that involve a photosensitizer drug and a device.

Discussions about the market indicate that dermatology is a highly fragmented market with large unmet needs and limited innovations. To cater to these requirements, companies are seeking inorganic routes such as the acquisition of DUSA by Sun Pharmaceutical for US$ 200 Mn. This acquisition helped Sun Pharmaceutical access DUSA’s patented drug?device combination Levulan, which is useful for photodynamic therapy for the treatment of Actinic Keratosis (AK), psoriasis, and acne. Thus, the foray of market players into the drug-device combination segment, coupled with increasing product research in light therapy devices, and the high adoption of photosensitizer drugs for photodynamic therapy, are among factors that are estimated to propel the photodynamic therapy market.

Dynamic Epidemiology for Skin Disorders and Associated Cancers to offer Growth Opportunities to the Photodynamic Therapy Market

The prevalence of various skin diseases, such as actinic keratosis, psoriasis, acne, rosacea, and others, varies across the globe. It depends upon the genetic makeup, skin type, as well as the lifestyle of people in a particular geography. Australia has the highest prevalence of actinic keratosis, and it has been estimated that 37–55% people in the country are affected with actinic keratosis. In the U.S., actinic keratosis is estimated to affect 10% of females and 26.5% males, while the prevalence of actinic keratosis in the UK is 15% in males and 6% in females. Thus, the growing prevalence of actinic keratosis is a significant factor that is projected to drive the revenue growth of the photodynamic therapy market over the forecast period.

Furthermore, psoriasis is among the common dermatology disorders and is the most prevalent autoimmune disease in the U.S. As per American Academy of Dermatology, as of 2017, 2.1% of the overall U.S. population suffered from psoriasis, which accounted for approximately 7.0 million psoriasis cases. Thus, the increasing prevalence of skin disorders is expected to promote the adoption of photodynamic therapy, which is expected to boost revenue growth in the global photodynamic therapy market.

Limited Competition in Photodynamic Therapy Offers Leverage to Existing Key Manufacturers

Photodynamic therapy is one of the most successful treatment options for actinic keratosis, skin diseases, and basal cell carcinomas. Hence, in case cryotherapy or topical treatment fails, physicians mostly prescribe photodynamic therapy over conventional treatments. Aminolevulinic acid is applied as a medication on the infected part of the skin, which is later is activated using a blue light source or an intense pulsed light source. At present, LEVULAN KERASTICK launched by Sun Pharmaceutical, Ameluz manufactured by Biofrontera, and Metvix offered by Galderma are among the major products that are commercially available in the photodynamic therapy market.

These popular brands are estimated to gain majority of the market share over the forecast period. This is also expected to create an opportunity for other dermatology product manufacturers to launch cost-effective products for photodynamic therapy to boost their revenue and strengthen their foothold in the market. Thus, limited competition in the photodynamic therapy market allows key manufacturers to strengthen their businesses by bringing innovative and upgraded phototherapy solutions in the market, thereby driving the global photodynamic therapy market.

Competitive Landscape

The competition section of the photodynamic therapy market features the profiles of the key players operating in the market based on their shares, differential strategies, product offerings, marketing approach, and company dashboard. Some of the key players operating in the photodynamic therapy market include Sun Pharmaceutical Industries Ltd., Galderma SA, and Biofrontera AG, which offer photosensitizer drugs, as well as Allergan Plc., Hologic, Inc., and Quest PharmaTech Inc., which offer therapy devices.

Definition

The photodynamic therapy market involves phototherapy treatment drugs and light therapy devices. Drug-based photodynamic treatment covers drug class - Hematoporphyrin Derivative (HpD), Aminolevulinic Acid (ALA), and others. Photodynamic therapy devices involve the use of a high-intensity bright light to activate the dormant photosensitizer drugs when they are injected into the body.

photodynamic therapy market analysis

About the Report

PMR has conducted a research study on the photodynamic therapy market for the forecast period 2019 to 2029. The photodynamic therapy market report offers a comprehensive evaluation of the business opportunities available in the photodynamic therapy market, along with insights on the consumption of photosensitizer drugs, incidence of diseases, awareness about skin cancer, and the competitive landscape of the photodynamic therapy market. The report elaborates on the macroeconomic factors that are influencing the dynamics of the photodynamic therapy market and its futuristic potential.

Segmentation

The report offers a comprehensive taxonomy of the photodynamic therapy market based on the product type, application, end users, and region. Different photodynamic therapy products in the market include photosenitizer drugs -Hematoporphyrin Derivative (HpD), Aminolevulinic Acid (ALA), benzoporphyrin derivatives, texaphyrins, chlorins, dyes, and devices such as disposable fiber optic light delivery devices and diode lasers. Photodynamic therapy finds major applications in basal cell carcinoma, actinic keratosis, and other applications. The photodynamic therapy market has been analyzed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA.

Additional Questions Answered

Some of the additional questions addressed in the photodynamic therapy market report are:

  • What is the revenue potential of the photodynamic therapy market across the regions of North America and Europe?
  • Who are the key competitors in the photodynamic therapy market and what are their portfolios?
  • What are the major challenges affecting the growth of the photodynamic therapy market?
  • How is the reimbursement landscape in the phototherapy treatment market impacting the growth of the market?

Research Methodology

The photodynamic therapy market has been estimated based on the consumption and supply-demand approach. The market was first calculated based on the consumption of photosensitizer drugs and the sales of light devices in different regions/countries, especially in the top 20 countries globally, for eight disease indications.

Other qualitative factors analyzed during the value estimation of photodynamic therapy include the level of awareness regarding skin disorders and available treatment methods. This information is further validated with thorough primary research (that includes surveys, interviews, and in-person interactions, along with the viewpoints of seasoned analysts) and secondary research (that comprises authentic trade journals, resourceful databases, and verified paid sources).

The research study on the photodynamic therapy market also includes the top trends and macro as well as microeconomic factors shaping the photodynamic therapy market. With this approach, the report on the photodynamic therapy market estimates the industry attractiveness of every major segment of the photodynamic therapy market over the forecast period.

PMR’s recent market study titled “Photodynamic therapy Market: Global Industry Analysis 2014–2018 and Forecast 2019–2029” comprises a comprehensive assessment of the key market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the photodynamic therapy market, growth prospects of the photodynamic therapy market have been obtained with maximum precision.

The report features unique and salient factors that are likely to have a significant impact on the development of the photodynamic therapy market during the forecast period. These factors can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the photodynamic therapy market in the coming years. The report provides detailed information about the current and future growth prospects of the photodynamic therapy market in the most comprehensive way for the better understanding of readers.

Chapter 1 – Executive Summary

The report commences with the executive summary of the photodynamic therapy market, which includes the summary of key findings and statistics. It also includes the market value (US$ million) estimates of the prominent segments of the photodynamic therapy market.

Chapter 2 – Market Introduction

Readers can find detailed taxonomy and definitions pertaining to the photodynamic therapy market in this chapter, which will help them understand the basic information about market dynamics, epidemiology study, cost structure, pricing analysis, list of key distributors and suppliers, list of key market participants in the photodynamic therapy market included in the report.

Chapter 3 – Global Photodynamic Therapy Market Analysis 2014–2018 & Opportunity Assessment 2019–2029 by Product Type

Based on the product type, the photodynamic therapy market has been segmented into photosensitizer drugs and devices. The photosensitizer drugs segment is further categorized into Hematoporphyrin derivative (HpD), Aminolevulinic acid (ALA), Benzoporphyrin derivative (BPD), Texaphyrins, Chlorins and Dyes. In this chapter, readers can find information about key trends and developments in the photodynamic therapy market and market attractive analysis based on the product type for each region.

Chapter 4 – Global Photodynamic Therapy Market Analysis 2014–2018 & Opportunity Assessment, 2019–2029 by Application

Based on the application, the photodynamic therapy market has been segmented into basal cell carcinoma, actinic keratosis and others. The others segment covers psoriasis, acne, rosacea, non-small cell lung cancer, esophageal cancer and ophthalmology. In this chapter, readers can find information about the disease epidemiology for each of the indications and developments in the photodynamic therapy market and market attractive analysis based on application for each region.

Chapter 5 – Global Photodynamic Therapy Market Analysis 2014–2018 & Opportunity Assessment, 2019–2029 by End User

Based on the end user, the photodynamic therapy market has been segmented into hospitals, private dermatology clinics, laser therapy centers, cancer treatment centers and spas & rejuvenation centers. In this chapter, readers can find information about the key trends and developments in the photodynamic therapy market and market attractive analysis based on end user for each region.

Chapter 6 – Global Photodynamic therapy Market Analysis 2014–2018 & Opportunity Assessment, 2019–2029 by Region

This chapter explains how the photodynamic therapy market is expected to grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceana and the Middle East & Africa (MEA).

Chapter 7 – North America Photodynamic Therapy Market Analysis 2014–2018 & Opportunity Assessment, 2019–2029

This chapter includes a detailed analysis of the growth of the North America Photodynamic therapy market along with a country-wise assessment for the U.S. and Canada. Readers can also find information on the regional trends in the photodynamic therapy market, along with regulations and epidemiology analysis for major indications along with market growth on the basis of product type, application, end user and country.

Chapter 8 – Latin America Photodynamic Therapy Market Analysis 2014–2018 & Opportunity Assessment, 2019–2029

Readers can find detailed information about factors such as photodynamic therapy pricing analysis, and regional trends that are impacting the growth of the Latin America photodynamic therapy market. This chapter also includes the growth prospects of the photodynamic therapy market in prominent LATAM countries such as Brazil, Mexico and the Rest of Latin America.

Chapter 9 – Europe Photodynamic Therapy Market Analysis 2014–2018 & Opportunity Assessment, 2019–2029

Important growth prospects of the photodynamic therapy market based on product type, application and end user in several European countries, such as Germany, the U.K., France, Italy, Spain, Russia, Poland and the rest of Europe have been included in this chapter.

Chapter 10 – East Asia Photodynamic Therapy Market Analysis 2014–2018 & Opportunity Assessment, 2019–2029

China and Japan are the prominent regions in the East Asia market. Thus, they are the prime subject of assessment to obtain growth prospects of the East Asia photodynamic therapy market. In this chapter, readers can find thorough information about the growth parameters of the East Asia photodynamic therapy market for the period 2019–2029.

Chapter 11 – South Asia Photodynamic Therapy Market Analysis 2014–2018 & Opportunity Assessment, 2019–2029

India, Thailand, Malaysia, Indonesia, Philippines, Rest of South Asia, are the prominent regions in the South Asia market. Thus, they are the prime subject of assessment to obtain growth prospects of the South Asia photodynamic therapy market. In this chapter, readers can find thorough information about the growth parameters and trends of the South Asia photodynamic therapy market for the period 2019–2029.

Chapter 12 – Oceana Photodynamic Therapy Market Analysis 2014–2018 & Opportunity Assessment, 2019–2029

Australia and New Zealand are the prominent regions in the Oceana market. Thus, they are the prime subject of assessment to obtain growth prospects based on product type, application and end user of the Oceana photodynamic therapy market for the period 2019–2029.

Chapter 13 – MEA Photodynamic Therapy Market Analysis 2014–2018 & Opportunity Assessment, 2019–2029

This chapter provides information on how the Photodynamic therapy market is expected to grow in major countries of the MEA region, such as GCC Countries and South Africa, during the period 2019–2029. Readers can find important factors that are estimated to have a significant impact on the growth of the photodynamic therapy market in MEA during the forecast period. This chapter also provides an overview of the regulations, drivers, restraints and trends prevalent in the MEA photodynamic therapy market.

Chapter 14 – Competition Landscape, Company Share and Company Profiles

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the photodynamic therapy market along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Market players featured in the photodynamic therapy report include Galderma S.A., Sun Pharmaceutical Industries Ltd., Biofrontera, Novartis AG, Allergan Plc, Valeant Pharmaceuticals International, Inc., Quest Pharmatech, Inc., and Hologic, Inc. (Cynosure Inc.)

Chapter 15 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 16 – Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the photodynamic therapy market.

Companies Profiles

  • Galderma S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Biofrontera
  • Novartis AG 
  • Allergan Plc
  • Valeant Pharmaceuticals International, Inc.
  • Quest Pharmatech, Inc.
  • Hologic, Inc. (Cynosure Inc.)
Back To Top